Overview

DCE MRI in Patients With Pancreatic Cancer

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who may have undergone chemotherapy for pancreatic cancer.
Phase:
N/A
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Oregon Health and Science University
Treatments:
Ferrosoferric Oxide